Replies to post #2253 on Skye Bioscience Inc (SKYE)

[frozenspokes]

All shareholders have feared a reverse split, however now that they have 20m in funding, they should be able to execute on some of the other milestones to increase value, specifically the 505(b)2 regulatory pathway. IF they can get some of those going, we should see some jumps in the share price. I still expect a reverse split of some sort, but a 5:1 will be significantly better than a 15:1. In my opinion doing a reverse split now vs waiting another 6 months AFTER some of the milestones are hit is immaterial especially since they have funding. I expect management agrees. NYSE is chomping to get them as a customer as they want a cannabinoid biotech as a customer since most see to be going on NASDAQ.